Technical Note No. CD 0336
Anaplasmosis - Serious Systemic Disease
Anaplasmosis in cattle is caused by
Anaplasma
marginale, a rickettsial pathogen that invades red blood
cells. The host animal begins to destroy (phagocytize) the
infected cells, resulting in a rapid reduction of circulating
red blood cells. After a significant level of phagocytosis
has occurred, the diseased animal may show signs of
anemia, jaundice and fever.
Anaplasmosis is spread by the transfer of blood from an
infected animal to a susceptible animal. Transmission can
be biological or mechanical. Ticks are a good biological
vector as the
Anaplasma organism can survive in ticks for
a long time. Biting insects such as horse flies, stable flies
and mosquitoes can transmit the organism mechanically
as can
Anaplasma-contaminated, reused needles and
dehorning instruments. Left uncontrolled, anaplasmosis
can spread to all naïve animals resulting in a potentially
devastating outbreak. Other factors contributing to outbreaks
include the number of carriers and the amount of
vector transference.
Cattle of all ages may become infected with the severity of
the infection increasing with age. In cattle under 12
months of age only a mild illness may be noticed but the
animals become a carrier for life. Cattle greater than 2
years of age show the most severe disease where mortality
rates can reach 50% if left untreated. Annual economic
loss to the cattle industry caused by anaplasmosis has
been reported in excess of $100 million.
1 These costs are
a compilation of death losses, lowered productivity,
decreased milk production, and reproductive disorders.
In the past anaplasmosis was commonly thought of as a
disease of southern cattle. However, as the industry has
become more global and interstate movement of cattle
has become more common, the disease is no longer just
a regional problem (Figure 1). Today the incidence is
much more nationwide and is routinely diagnosed outside
the traditional anaplasmosis endemic areas.
Anaplasma vaccines previously available have been withdrawn
from the market as a result of side-effects and efficacy
issues. Currently, the only available vaccine is a
modified live vaccine licensed for use in California for
animals less than 1 year of age. In addition, vaccinated
animals may show a positive reaction to diagnostic tests,
complicating export, interstate movement of animals and
eradication of the organism.
Aureomycin in the Feed to Control Anaplasmosis
Aureomycin is a broad spectrum antimicrobial approved in
the US for the control of anaplasmosis (Table 1), in addition
to being active against a wide variety of gram-positive
and gram negative bacteria, spirochetes, rickettsia, protozoa,
and chlamydia. Studies have shown that Aureomycin
is effective (at 0.5 mg/lb body weight) not only in preventing
death losses
2 due to
anaplasmosis, but also in controlling
the infection in carrier animals, preventing the spread
of the disease.
3
Oxytetracycline, the other commercially available "tetracycline"
antibiotic, does not have an approved anaplasmosis
claim for feed use.
Anaplasma marginale, the causative
agent of anaplasmosis, is an intracellular pathogen.
Cellular membranes consist of fatty substances, and
research has demonstrated that chlortetracycline has
greater lipid solubility than oxytetracycline. Therefore, one
might expect that chlortetracycline would deliver more
drug to the
A. marginale pathogens and, therefore, be a
more effective antimicrobial than oxytetracycline.
Feeding Trials Show the Benefits of Anaplasmosis Control
Numerous studies have been conducted with Aureomycin
in pasture cattle for control of anaplasmosis. Five
university trials were conducted with cows and their suckling
calves. The pairs had access to either a medicated
(Aureomycin) or non-medicated salt/mineral mix during
some or all of the grazing season. Researchers noted that
calves suckling cows with access to the medicated mix
had increased weaning weights (Table 2).
Experiments have also been conducted with replacement
heifers receiving either medicated (Aureomycin) or non-
medicated supplements or salt/mineral mixes for the control
of anaplasmosis. In these studies, the feeds were
available approximately 30 days prior to breeding in all
three studies, and for 30 days post-initiation of breeding in
experiment 3 (Table 3). Replacement heifers receiving the
medicated mix had significantly higher pregnancy rates in
all three studies as compared to heifers receiving the
non-medicated feed.
Feeding Aureomycin is the practical, convenient, economical
method for controlling anaplasmosis in the herd. Feed
manufacturers offer a variety of feeds, and free choice
minerals and blocks containing this broad-spectrum
antimicrobial.
Summary
- Aureomycin is approved for administration in the
feed to control anaplasmosis in beef cattle (refer to Table 1).
- Aureomycin in the feed is the practical, convenient,
economical way to control anaplasmosis in the herd.
- With Aureomycin in the feed for anaplasmosis control,
there is no need for monthly injections during the vector season.
- Cattle can receive Aureomycin right up to slaughter;
no withdrawal period is required.
Literature Cited
- Bovine Anaplasmosis, Wilhelm Heinrich Stoltz from Kirk’s Current Vet Therapy IV, published by Saunders (pp 588-596).
- Brock WE, Pearson CC, Staley EE, Kliewer, IO. 1957. The prevention
of anaplasmosis by feeding chlortetracycline. J Am Vet
Med Assoc May: 445-446.
- Richey EJ, Brock WE, Kliewer IO, Jones EW. 1977. Low levels
of chlortetracycline for anaplasmosis. Am J Vet Res 38:171-172.
- Kuhl G and L Conah. 1992. Medicated Mineral Mixes for
Grazing Cattle. KSU Extension Leaflet.
- Rae DO et al. 1993. Reproductive performance of beef heifers:
Effects of vulvo-vaginitis, Ureaplasma diversum and pre breeding
antibiotic administration. Theriogenology 40: 497-508.
- Saltman RL et al. 1998. Effects of an oral antibiotic on fertility in
range beef cattle. Bovine Pract 33:121-123.
- Rae DO et al. 2002. Effect of chlortetracycline in a trace mineral
salt mix on fertility traits in beef cattle females in Florida. J Anim
Sci 80: 880-885.
Aureomycin® is a registered trademark of Alpharma Inc.
Animal Health Division Data in Alpharma research file.
Copyright © 2002 Alpharma Inc.
Alpharma Inc.
One Executive Drive
Fort Lee, NJ 07024 USA
1-888-897-8657
Additional technical information is available at
www.alpharma.com